What EmbryoGlue actually is
EmbryoGlue is a brand name for a hyaluronate-enriched embryo-transfer medium. It is not a literal adhesive and it does not physically glue an embryo to the uterine lining. The embryo is briefly placed in a culture medium containing a higher concentration of hyaluronan before transfer.
The biological idea is plausible: hyaluronan naturally occurs in the reproductive tract and may influence cell adhesion and embryo-endometrium interactions. The commercial question is whether adding more hyaluronan to transfer medium meaningfully increases the chance of live birth for patients undergoing IVF.
That second question is where the evidence is less settled than the product name implies.
What does the HFEA say in 2026?
The UK's Human Fertilisation and Embryology Authority currently rates hyaluronate-enriched pre-transfer culture medium, including products such as EmbryoGlue, amber for improving the chance of having a baby for most fertility patients.
Amber means the evidence is conflicting: some moderate- or high-quality studies suggest benefit while others do not. The HFEA does not rate it green, which would indicate that the balance of high-quality evidence shows the add-on improves the treatment outcome.
The authority also notes that no additional known safety risks have been identified for the patient or child from the medium itself. So the decision is less about a major known safety hazard and more about uncertain incremental benefit versus cost.
| Question | Evidence-focused answer |
|---|---|
| Is EmbryoGlue literally glue? | No. It is a hyaluronate-enriched transfer medium. |
| Is it proven to improve live birth for most patients? | Not clearly. HFEA rates the evidence amber/conflicting. |
| Is there a known major added safety risk? | HFEA reports no additional known risks from the add-on itself. |
| Should every IVF patient buy it? | The evidence does not support treating it as a universally proven necessity. |
Why studies can look positive without settling the question
A fertility add-on can improve one intermediate outcome without clearly improving cumulative live birth. Studies can also differ in patient age, embryo stage, fresh versus frozen transfer, number of embryos transferred, underlying infertility diagnosis and the exact transfer medium used.
Small studies are particularly vulnerable to chance findings. When multiple trials point in different directions, a systematic review or regulator's evidence grading is more useful than the most optimistic single paper.
Patients should therefore ask whether a clinic's quoted “success improvement” comes from its own uncontrolled experience, one published trial, or a pooled review of randomized evidence.
How much does EmbryoGlue cost?
Clinics price transfer-media add-ons very differently. Some bundle the medium into the embryo-transfer laboratory fee, while others charge a few hundred dollars as a separate add-on. International clinics may include it automatically in an IVF package.
The important cost question is not just the sticker price. Ask whether paying for EmbryoGlue changes anything else in the treatment plan, whether it is charged per transfer, and whether the fee is refunded if the transfer is cancelled before an embryo is thawed or placed in medium.
If a clinic charges separately, compare that expense with other uses of the same money: medication, an additional frozen transfer fund, storage, transportation, counseling or another evidence-based part of care.
The opportunity-cost problem
Fertility treatment budgets are finite. HFEA explicitly advises self-pay patients to consider whether money spent on unproven or uncertain add-ons might be better used for additional routine treatment cycles.
That does not mean a $300 add-on is automatically a bad decision. It means its expected benefit should be evaluated against what else $300 buys in that patient's plan.
The comparison becomes especially important when several add-ons are stacked together. EmbryoGlue, assisted hatching, time-lapse imaging, receptivity testing and immune therapies can turn a base transfer into a much larger bill even when each individual charge feels modest.
Who might plausibly be offered EmbryoGlue?
Clinics may be more likely to discuss hyaluronate-enriched transfer media after previous implantation failure or when a patient strongly wants to use every low-risk option. But being offered an add-on to a subgroup does not automatically mean robust evidence proves benefit in that subgroup.
Ask the clinic to state the exact reason it believes the add-on is relevant in your case and whether that rationale is supported by randomized evidence for patients with similar history.
“Your previous transfer failed” is emotionally compelling, but a failed transfer is common enough that it does not by itself prove a missing laboratory add-on caused the failure.
What outcome should you care about?
Implantation and clinical pregnancy are meaningful, but most patients ultimately care about live birth. If a study or clinic brochure reports a higher implantation rate, ask whether live birth also improved and whether the study was large enough to detect that difference.
Cumulative live birth is even more patient-centered when multiple embryos from one retrieval are available. An intervention that shifts which transfer succeeds first may not necessarily change whether the patient eventually has a baby from the retrieval.
That is why evidence summaries that prioritize live birth are more useful than marketing built around implantation percentages.
Questions to ask before saying yes
Ask how much the add-on costs per transfer and whether it is already included in the clinic's standard medium. Ask which randomized trials or systematic review the clinic relies on and what outcome improved in those studies.
Then ask whether your clinic uses it for everyone or only selected patients. If everyone receives it automatically, ask whether there is an opt-out and whether the bill changes.
Finally, ask what the clinic would recommend if cost were not part of the conversation. A recommendation that changes when the patient asks about price is worth understanding.
How EmbryoGlue differs from other IVF add-ons
EmbryoGlue is a laboratory transfer-medium modification. It should not be confused with endometrial receptivity testing, embryo genetic testing, assisted hatching, platelet-rich plasma, immune therapies or microbiome testing.
Each add-on has a different biological hypothesis and evidence base. Bundling them mentally into a general category of “things that improve implantation” is a mistake.
ConceiveGuide's approach is to evaluate each one separately: mechanism, best available evidence, known risks, cost, and whether the outcome being sold is actually live birth.
Frequently asked questions
Does EmbryoGlue increase IVF success rates?
The evidence is conflicting. The HFEA currently rates hyaluronate-enriched transfer medium amber for improving the chance of having a baby for most patients.
Is EmbryoGlue actually glue?
No. It is an embryo-transfer culture medium enriched with hyaluronan.
Is EmbryoGlue safe?
The HFEA reports no additional known risks for the patient or child from the add-on itself, while noting uncertainty about effectiveness.
How much does EmbryoGlue cost?
Clinic pricing varies and may be bundled or billed separately. Request the exact per-transfer fee and cancellation/refund terms.
Is EmbryoGlue worth it after a failed transfer?
A prior failed transfer can prompt discussion, but it does not prove the add-on will help. Ask what evidence supports use in patients with your specific history.
Related ConceiveGuide articles
Sources and evidence checked
Published prices are point-in-time observations, not quotes. Fertility treatment fees, insurance rules, eligibility criteria and clinical recommendations can change. Request a written estimate and discuss medical decisions with your treating fertility specialist.
Should EmbryoGlue be routine or optional?
If a clinic uses hyaluronate-enriched medium for every transfer at no additional charge, the personal financial decision is small. If it charges separately, the evidence threshold becomes more important because the patient is explicitly buying an uncertain incremental benefit.
Ask whether the laboratory's standard transfer medium already contains hyaluronan at some concentration. The branded add-on conversation can otherwise oversimplify what is actually a spectrum of laboratory media.
What would change our view?
A consistent improvement in live birth across large randomized trials, replicated in clearly defined patient groups, would strengthen the case. A benefit limited to implantation without a corresponding live-birth advantage would be less compelling.
Until then, ConceiveGuide classifies EmbryoGlue as a reasonable question to discuss—not a box every self-pay patient needs to tick.
How ConceiveGuide evaluates EmbryoGlue evidence and add-on pricing
For cost articles, we separate the headline procedure fee from the amount a patient can actually be billed. Fertility clinics package monitoring, laboratory work, anesthesia, medications, cryostorage, donor services and outside genetic-lab fees differently, so two identical-looking prices can describe very different scopes.
For evidence questions, we prioritize current professional guidance, systematic reviews and regulators or professional bodies that grade treatment add-ons. A clinic's marketing claim can be useful for understanding what is being sold, but it is not treated as proof that an intervention improves live-birth outcomes.
For every quote, ask for four things in writing: what is included, what is excluded, what happens if a cycle is cancelled, and which fees are paid to third parties rather than the clinic. Those four fields explain most of the gap between an advertised fertility price and the final bill.
Decision checklist
- Ask what clinical problem the test or treatment is intended to solve.
- Request a written, itemized estimate rather than a verbal package price.
- Separate clinic charges from pharmacy, anesthesia, genetic laboratory, donor-bank and storage charges.
- Ask what becomes nonrefundable if the cycle is cancelled or treatment changes.
- Confirm whether the quoted outcome is pregnancy, ongoing pregnancy or live birth.
- Ask whether the evidence applies to patients with your age, diagnosis and treatment history.
- Verify insurance authorization before treatment if you expect coverage.
- Keep a copy of the quote, consent forms and benefit verification for later comparison.
Fertility care is unusually vulnerable to emotional decision-making because time, hope and money are all involved at once. A written checklist slows the process down enough to make the financial and evidence questions visible before a consent form becomes a bill.
What to record in your treatment spreadsheet
For this topic, create columns for the quoted base price, medication, monitoring, laboratory work, outside-provider fees, storage, travel, cancellation policy and the date the quote expires. Record the source of every number. Fertility pricing changes often enough that an undated estimate can become misleading within a few months.
Also record the medical endpoint attached to the price. A package that covers one retrieval is different from one that covers one transfer, and a refund tied to pregnancy is different from one tied to live birth. Precise labels make later comparisons much easier.
What to record in your treatment spreadsheet
For this topic, create columns for the quoted base price, medication, monitoring, laboratory work, outside-provider fees, storage, travel, cancellation policy and the date the quote expires. Record the source of every number. Fertility pricing changes often enough that an undated estimate can become misleading within a few months.
Also record the medical endpoint attached to the price. A package that covers one retrieval is different from one that covers one transfer, and a refund tied to pregnancy is different from one tied to live birth. Precise labels make later comparisons much easier.
What to record in your treatment spreadsheet
For this topic, create columns for the quoted base price, medication, monitoring, laboratory work, outside-provider fees, storage, travel, cancellation policy and the date the quote expires. Record the source of every number. Fertility pricing changes often enough that an undated estimate can become misleading within a few months.
Also record the medical endpoint attached to the price. A package that covers one retrieval is different from one that covers one transfer, and a refund tied to pregnancy is different from one tied to live birth. Precise labels make later comparisons much easier.
What to record in your treatment spreadsheet
For this topic, create columns for the quoted base price, medication, monitoring, laboratory work, outside-provider fees, storage, travel, cancellation policy and the date the quote expires. Record the source of every number. Fertility pricing changes often enough that an undated estimate can become misleading within a few months.
Also record the medical endpoint attached to the price. A package that covers one retrieval is different from one that covers one transfer, and a refund tied to pregnancy is different from one tied to live birth. Precise labels make later comparisons much easier.